Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer - Petrylak, D P; Tangen, C M; Hussain, M H; Lara, P N, Jr.; Jones, J A; Taplin, M E; Burch, P A; Berry, D; Moinpour, C; Kohli, M; Benson, M C; Small, E J; Raghavan, D; Crawford, E D (N Engl J Med, 2004)